Tag Archives: AbbVie

AbbVie halts late-stage trial for lung cancer drug Rova-T

(Reuters) – AbbVie Inc said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung cancer, following recommendations made by an independent data monitoring committee. The committee’s recommendations were based on shorter overall survival in the Rova-T arm, compared with the topotecan control arm,… Read More »

AbbVie, Roche combo treatment meets main goal of leukemia trial

FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. REUTERS/Brendan McDermid/File Photo (Reuters) – AbbVie Inc and Roche Holding AG said on Wednesday their immunotherapy delayed the progression of a type of blood and bone marrow cancer when used in… Read More »